Mounjaro Overtakes Augmentin As India's Top-Selling Drug

Mint · business

Eli Lilly's Mounjaro has become India's top-selling drug, surpassing GlaxoSmithKline's Augmentin. This shift signifies a major change in the Indian pharmaceutical market's economics, moving from a focus on volume and affordable medicines to high-value treatments for diabetes and weight loss. Mounjaro's success highlights the growing demand for GLP-1 drugs, indicating a new era for the country's pharma industry. The market is now being reshaped by these innovative and sought-after medications.